HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

99mTc-fanolesomab Palatin Technologies.

Abstract
99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.
AuthorsCharito Love, Christopher J Palestro
JournalIDrugs : the investigational drugs journal (IDrugs) Vol. 6 Issue 11 Pg. 1079-85 (Nov 2003) ISSN: 1369-7056 [Print] England
PMID14600841 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies, Monoclonal
  • Lewis X Antigen
  • Radiopharmaceuticals
  • Technetium
  • techneticum TC-99M fanolesomab
Topics
  • Animals
  • Antibodies, Monoclonal (adverse effects, pharmacokinetics)
  • Clinical Trials as Topic
  • Humans
  • Infections (diagnosis)
  • Injections, Intravenous
  • Lewis X Antigen (metabolism)
  • Radiopharmaceuticals (adverse effects, pharmacokinetics)
  • Structure-Activity Relationship
  • Technetium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: